New oncology model from Humana, Evolent and American Oncology Network eliminates prior authorization burden
Business Wire•10/11/2026•10:00 ET
0
Key Highlights
- ➤Humana, Evolent and AON launched an oncology model across eight states.
- ➤Qualifying AON practices can avoid traditional prior authorization for most anticancer therapies.
- ➤Evolent supports the model with oncology pathways, quality programs and performance reporting.
- ➤AON’s network represents more than 350 providers across 21 states.
Expert Statements
Dr. Traci Granston, Humana Vice President of Clinical Innovation
“We are committed to easing access to quality oncology care for our members and helping to reduce the administrative burden for providers”
Dr. Traci Granston, Humana Vice President of Clinical Innovation
“A cancer diagnosis is difficult news to hear. By making access to affordable, quality care even easier to navigate and enabling more efficient use of high-cost therapies, we are working to ease the burden of cancer treatment. When members can accelerate the start of cancer treatment, the probability of better health outcomes increases.”
Dr. Stephen "Fred" Divers, AON Chief Medical Officer
“We are excited to support Humana members living with cancer through this model. Community oncology centers are the lifeblood of the cancer treatment landscape. Through this partnership, we’re bringing them the latest evidence and proven quality interventions to support their treatment decisions, while avoiding the typical friction around approvals that frustrates patients and providers.”
Susan Sabo-Wagner, AON Vice President of Clinical Innovation
“Clinical innovation is not simply about introducing new technology. It is about creating systems and partnerships that make it easier for our care teams to do what is right for patients”
Susan Sabo-Wagner, AON Vice President of Clinical Innovation
“This collaboration represents an opportunity to shift from retrospective approvals toward proactive clinical quality improvement, where physicians and health plans work from trusted clinical information to support timely, appropriate care.”
Dr. Von Nguyen, Evolent Chief Medical Officer
“We’re honored by the trust that Humana has placed in us over the years to support its members in some of their most pivotal health moments”
Dr. Von Nguyen, Evolent Chief Medical Officer
“This new oncology model is emblematic of a partnership that is energized by the opportunity to rethink healthcare and innovate. Together with AON, we’re building a model that reduces reliance on prior authorization by aligning payers and providers around quality and affordability.”
New oncology model from Humana, Evolent and American Oncology Network eliminates prior authorization burden
Program launched at American Oncology Network clinics across eight states.
Get started
Create a free account to read the full story.